Knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway

Ribosomal protein L34 (RPL34), belonging to the L34E family of ribosomal proteins, was reported to be dysregulated in several types of cancers and plays important roles in tumor progression. However, the expression and roles of RPL34 in human glioma remain largely unknown. Thus, the objective of this study was to investigate the expression and role of RPL34 in glioma. We report here that RPL34 is highly expressed in human glioma tissues and cell lines. Knockdown of RPL34 markedly inhibited the proliferation, migration, and invasion, as well as prevented the epithelial‐mesenchymal transition phenotype in glioma cells. Further, mechanistic analysis showed that knockdown of RPL34 significantly downregulated the levels of p‐JAK and p‐STAT3 in glioma cells. Taken together, our findings indicated that knockdown of RPL34 inhibits the proliferation and migration of glioma cells through the inactivation of JAK/STAT3 signaling pathway. Thus, RPL34 may serve as a potential therapeutic target for the treatment of glioma.

• Publication year

  2018

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2018-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.27592PMID 30216512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition

  2020cited by this paper
• Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis

  2019cited by this paper
• Overexpression of ALK4 inhibits cell proliferation and migration through the inactivation of JAK/STAT3 signaling pathway in glioma.

  2018cited by this paper
• IL-6 increases SDCBP expression, cell proliferation, and cell invasion by activating JAK2/STAT3 in human glioma cells.

  2017cited by this paper
• Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.

  2017cited by this paper
• Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.

  2017cited by this paper
• Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells

  2016cited by this paper
• Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells.

  2016cited by this paper
• Current and future strategies for treatment of glioma

  2016cited by this paper
• Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control

  2016cited by this paper
• RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells

  2015cited by this paper
• Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.

  2015cited by this paper
• STAT3 Signaling in Cancer

  2015cited by this paper
• miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway

  2015cited by this paper
• Recent advances in therapy for glioblastoma.

  2010cited by this paper
• Down-Regulation of Stat3 Decreases Invasion Activity and Induces Apoptosis of Human Glioma Cells

  2010cited by this paper
• SNAI2/Slug promotes growth and invasion in human gliomas

  2010cited by this paper
• The transcriptional network for mesenchymal transformation of brain tumors

  2009cited by this paper
• EMT, the cytoskeleton, and cancer cell invasion

  2009cited by this paper
• Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas

  2009cited by this paper
• Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cited by this paper
• Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators

  2008cited by this paper
• Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas: Correlation With EGFR Status, Tumor Grade, and Survival

  2006cited by this paper
• The roles of ribosomal proteins in the structure assembly, and evolution of the large ribosomal subunit.

  2004cited by this paper
• The JAK/STAT signaling pathway

  2004cited by this paper
• Molecular mechanisms of glioma invasiveness: the role of proteases

  2003cited by this paper
• JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription.

  2002cited by this paper
• Ribosomal proteins in cell proliferation and apoptosis.

  1999cited by this paper
• Promoter elements controlling developmental and environmental regulation of a tobacco ribosomal protein gene L34

  1996cited by this paper
• Extraribosomal functions of ribosomal proteins.

  1996cited by this paper

• Proteomic insights into Helicobacter pylori infection in stomach cells, revealing host response and host-targeted therapeutics repurposing

  2026cites this paper
• Ribosomal Proteins as Exosomal Cargo: Random Passengers or Crucial Players in Carcinogenesis?

  2025cites this paper
• Ribosome biogenesis-related gene signature predicts prognosis and immune landscape in glioma and identifies UTP20 as a therapeutic target

  2025cites this paper
• Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway

  2025cites this paper
• TGF-β2 Induces Ribosome Activity, Alters Ribosome Composition and Inhibits IRES-Mediated Translation in Chondrocytes

  2024cites this paper
• Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF Complex-Mediated Ubiquitination

  2024influential citation
• Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy

  2024cites this paper
• The dark side of mRNA translation and the translation machinery in glioblastoma

  2023cites this paper
• Translational regulation of cell invasion through extracellular matrix—an emerging role for ribosomes

  2023cites this paper
• Artificial Downregulation of Ribosomal Protein L34 Restricts the Proliferation and Metastasis of Colorectal Cancer by Suppressing the JAK2/STAT3 Signaling Pathway

  2023cites this paper
• Microenvironmental stiffness induces metabolic reprogramming in glioblastoma

  2023cites this paper
• Roles of STAT3 in the pathogenesis and treatment of glioblastoma

  2023cites this paper
• Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance

  2022cites this paper
• EGR1 Enhances Lymphangiogenesis via SOX18-Mediated Activation of JAK2/STAT3 Pathway

  2022cites this paper
• Suppression of RPL34 Inhibits Tumor Cell Proliferation and Promotes Apoptosis in Glioblastoma

  2022cites this paper
• The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma

  2021cites this paper
• Protective Effect of Dictyophora Polysaccharides on Sodium Arsenite-Induced Hepatotoxicity: A Proteomics Study

  2021cites this paper
• Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

  2021cites this paper
• Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins

  2021cites this paper
• Downregulated ribosomal protein L39 inhibits trophoblast cell migration and invasion by targeting E‐cadherin in the placenta of patients with preeclampsia

  2021cites this paper
• RPL34‐AS1–induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2‐P53 pathway

  2021cites this paper
• Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition

  2020cites this paper
• Ribosomal protein L34 is a potential prognostic biomarker and therapeutic target in hilar cholangiocarcinoma

  2020cites this paper
• 6 α-Hydroxy-4[14], 10[15]-guainadien-8β, 12-olide induced cell cycle arrest via modulation of EMT and Wnt/β-catenin pathway in HER-2 positive breast cancer cells.

  2020cites this paper
• Knockdown of RPL34 suppresses osteosarcoma cell proliferation likely through EIF3/FAU signaling pathway

  2019cites this paper
• RPL34-AS1 functions as tumor suppressive lncRNA in esophageal cancer.

  2019cites this paper
• Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis

  2019cites this paper